The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Find your nearest AHSN
Remote patient monitoring - DOC@HOME®
DOC@HOME is an accredited and regulatory compliant health platform which enable healthcare professionals to improve quality, efficiency and productivity.Docobo has been working closely with health and social care services for 20 years, enhancing and improving knowledge and product development to ensure we continue to deliver real and reliable solutions and optimise our clients’ adoption of ‘digital’ in a coherent interoperable system. Adoption is most successful when it is an evolutionary process, which assures effective change, with confidence and momentum.
Dermicus is an NHSX DTAC approved specialist teledermatology platform for the remote diagnosis and management of skin cancer, general skin lesions and wounds. Dermicus is securely integrated into electronic patient records systems in primary and secondary care using the NHS IM1 pairing, FHIR and other integration standards. All patient data and information security meet the highest standards required by the NHS, validated by an ISO 27001 accreditation.
We are a small team united by a common cause – a deep commitment to supporting sustainable healthcare and transforming the delivery of care to patients living with multimorbidity through use of technology and new ways of working. We combine a wealth of knowledge to bring a variety of perspectives and complementary skills to the challenges of the evolving face of NHS Primary Care and work in harmony with forward thinking GP practices and clinicians who share our passion for such innovation.
Care Homes Digital Maturity Dashboard
There is limited information on digital maturity in care homes within London. Building on the EoLC Care Home data packs created in 2018 and 2019, our Healthy Ageing and Informatics Teams were commissioned to create a user friendly and useful digital maturity dashboard for care homes across London. This project was led by the Health Innovation Network and funded by the Digital First London region team.
Improving medication safety in care homes using quality improvement methods
Marian House Nursing Home (located in Sutton Coldfield, Birmingham) successfully implemented a quality improvement project to improve the safety of medicines rounds for residents in their care.
REST EASY Training - Mental health support for schools, families and businesses.
REST EASY Training offer a simple, affordable, effective wellbeing methodology for schools, staff & families. The method forms part of a whole school approach & intervention strategy that teaches children, parents & staff how to recognise & manage emotions using our simple REST EASY acronym. We are evaluated against the NICE guidelines for social, emotional & mental wellbeing needs in schools & meet all DfE pinciples & SEL requirements.
HN is a healthcare company that delivers AI guided case-finding, clinical coaching, remote monitoring, and virtual ward solutions to the NHS. They combine health coaching with data-science expertise for Primary Care Networks (PCN) throughout England. The service is managed entirely by HN and is fully financed by the Additional Roles Reimbursement Scheme (ARRS). The company's health coaches work with patients to improve their health literacy, build confidence and empowerment and get them to the point where they are pro-active in managing their health. This reduces their reliance on the system and alleviates pressure on primary care resources and GP workloads.
PCL Connect is an elderly-customised ecosystem of devices and applications to connect our seniors with carers, doctors and family members seamlessly using higher-end technology. Our easy-to-use tablet provides elderly patients with an opportunity to instantly make calls and share images with their relatives, carers or doctors. Our wearable sensors collect vital measurements and share them with all authorised parties to spot trends of health deterioration and provide preventive measures before they get severe. Our technology saves time, money and lives.
Oxford AHSN support helps digital innovators develop and roll out automated surgery follow-up call
Ufonia is an innovative digital health company based in Oxford comprising a team of clinical, software and artificial intelligence experts. It was founded by a neurosurgeon with experience leading NHS digital programmes and is applying AI technologies to solve some of the biggest challenges in healthcare.
MyWay Digital Health (MWDH) is a University of Dundee spin out. MyWay Diabetes (MWD) their flagship product, developed with NHS Scotland, is the only self-management platform globally to be scaled across an entire country ( >500,000 web users, >65,000 data registrants). MyDiabetes Clinical is a complementary clinician platform supporting individual/ population evidence-based management/ decision support, risk profiling and analytics. MWDH is NHS Innovation Accelerator Alumni, has won Digital Leaders impact award (2021) European ehealth adopters award (2017), DiabetesUK QiC self-management award (2015).
Biologics for treating severe asthma: Reslizumab, Benralizumab, Mepolizumab and Omalizumab
Less than 50% of severe asthma patients have eosinophil-driven disease (Wenzel2005) and Biologics are designed to control the number of eosinophil cells (Asthma UK). Only 10.8% of eligible severe asthma patients have access to biologic medicines today in the UK. Increasing the use of biologics appropriately would reduce use of Oral corticosteroids (OCS), associated with negative side effects, and exacerbations, causing 75,000 annual UK hospital admissions, each costing £1500.
Measuring fractional exhaled nitric oxide (FeNO) concentration in asthma: products NIOX VERO and NObreath
FeNO (Fractional exhaled Nitric Oxide) testing alongside the recommended NICE diagnostic tests, will help enable more accurate diagnosis of asthma. Over 120,000 patients a year, 30% of the asthma population, are wrongly diagnosed and given inappropriate medication. This project will look to reduce the use of steroids and improve diagnosis, enabling correct adjustments or the right medication to be prescribed. FeNO is indicative of the severity of airway inflammation.